<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1986-07-21" modified="2017-12-20" version="242">
<accession>P00519</accession>
<accession>A3KFJ3</accession>
<accession>Q13869</accession>
<accession>Q13870</accession>
<accession>Q16133</accession>
<accession>Q17R61</accession>
<accession>Q45F09</accession>
<name>ABL1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Tyrosine-protein kinase ABL1</fullName>
<ecNumber evidence="65 70">2.7.10.2</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Abelson murine leukemia viral oncogene homolog 1</fullName>
</alternativeName>
<alternativeName>
<fullName>Abelson tyrosine-protein kinase 1</fullName>
</alternativeName>
<alternativeName>
<fullName>Proto-oncogene c-Abl</fullName>
</alternativeName>
<alternativeName>
<fullName>p150</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">ABL1</name>
<name type="synonym">ABL</name>
<name type="synonym">JTK7</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1986" name="Cell" volume="47" first="277" last="284">
<title>Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene.</title>
<authorList>
<person name="Shtivelman E."/>
<person name="Lifshitz B."/>
<person name="Gale R.P."/>
<person name="Roe B.A."/>
<person name="Canaani E."/>
</authorList>
<dbReference type="PubMed" id="3021337"/>
<dbReference type="DOI" id="10.1016/0092-8674(86)90450-2"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM IA)</scope>
<scope>ALTERNATIVE SPLICING</scope>
<scope>VARIANT PRO-140</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1989" name="Oncogene" volume="4" first="1477" last="1481">
<title>Nucleotide sequence analysis of human abl and bcr-abl cDNAs.</title>
<authorList>
<person name="Fainstein E."/>
<person name="Einat M."/>
<person name="Gokkel E."/>
<person name="Marcelle C."/>
<person name="Croce C.M."/>
<person name="Gale R.P."/>
<person name="Canaani E."/>
</authorList>
<dbReference type="PubMed" id="2687768"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM IA)</scope>
<source>
<tissue>Fibroblast</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1995" name="Genomics" volume="27" first="67" last="82">
<title>Sequence and analysis of the human ABL gene, the BCR gene, and regions involved in the Philadelphia chromosomal translocation.</title>
<authorList>
<person name="Chissoe S.L."/>
<person name="Bodenteich A."/>
<person name="Wang Y.-F."/>
<person name="Wang Y.-P."/>
<person name="Burian D."/>
<person name="Clifton S.W."/>
<person name="Crabtree J."/>
<person name="Freeman A."/>
<person name="Iyer K."/>
<person name="Jian L."/>
<person name="Ma Y."/>
<person name="McLaury H.-J."/>
<person name="Pan H.-Q."/>
<person name="Sarhan O.H."/>
<person name="Toth S."/>
<person name="Wang Z."/>
<person name="Zhang G."/>
<person name="Heisterkamp N."/>
<person name="Groffen J."/>
<person name="Roe B.A."/>
</authorList>
<dbReference type="PubMed" id="7665185"/>
<dbReference type="DOI" id="10.1006/geno.1995.1008"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS IA AND IB)</scope>
<source>
<tissue>Lung</tissue>
</source>
</reference>
<reference key="4">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS VAL-706; PRO-852; SER-900 AND LEU-972</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Nature" volume="429" first="369" last="374">
<title>DNA sequence and analysis of human chromosome 9.</title>
<authorList>
<person name="Humphray S.J."/>
<person name="Oliver K."/>
<person name="Hunt A.R."/>
<person name="Plumb R.W."/>
<person name="Loveland J.E."/>
<person name="Howe K.L."/>
<person name="Andrews T.D."/>
<person name="Searle S."/>
<person name="Hunt S.E."/>
<person name="Scott C.E."/>
<person name="Jones M.C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Ashwell R.I.S."/>
<person name="Babbage A.K."/>
<person name="Babbage S."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Banerjee R."/>
<person name="Barker D.J."/>
<person name="Barlow K.F."/>
<person name="Bates K."/>
<person name="Beasley H."/>
<person name="Beasley O."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burford D."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Chen Y."/>
<person name="Clarke G."/>
<person name="Clark S.Y."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Crosier M."/>
<person name="Cummings A.T."/>
<person name="Davies J."/>
<person name="Dhami P."/>
<person name="Dunn M."/>
<person name="Dutta I."/>
<person name="Dyer L.W."/>
<person name="Earthrowl M.E."/>
<person name="Faulkner L."/>
<person name="Fleming C.J."/>
<person name="Frankish A."/>
<person name="Frankland J.A."/>
<person name="French L."/>
<person name="Fricker D.G."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Ghori J."/>
<person name="Gilbert J.G.R."/>
<person name="Glison C."/>
<person name="Grafham D.V."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Guy J."/>
<person name="Hall R.E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Harrison E.S.I."/>
<person name="Hart E.A."/>
<person name="Heath P.D."/>
<person name="Henderson C.D."/>
<person name="Hopkins B.L."/>
<person name="Howard P.J."/>
<person name="Howden P.J."/>
<person name="Huckle E."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A.A."/>
<person name="Kay M."/>
<person name="Keenan S."/>
<person name="Kershaw J.K."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A."/>
<person name="Laird G.K."/>
<person name="Langford C."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Leversha M."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Lovell J."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="McLaren S."/>
<person name="McLay K.E."/>
<person name="McMurray A."/>
<person name="Milne S."/>
<person name="Nickerson T."/>
<person name="Nisbett J."/>
<person name="Nordsiek G."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Porter K.M."/>
<person name="Pandian R."/>
<person name="Pelan S."/>
<person name="Phillimore B."/>
<person name="Povey S."/>
<person name="Ramsey Y."/>
<person name="Rand V."/>
<person name="Scharfe M."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Sims S.K."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C.A."/>
<person name="Swarbreck D."/>
<person name="Sycamore N."/>
<person name="Tester J."/>
<person name="Thorpe A."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Thomas D.W."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="West A.P."/>
<person name="Whitehead S.L."/>
<person name="Willey D.L."/>
<person name="Williams S.A."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Young L."/>
<person name="Ashurst J.L."/>
<person name="Coulson A."/>
<person name="Blocker H."/>
<person name="Durbin R.M."/>
<person name="Sulston J.E."/>
<person name="Hubbard T."/>
<person name="Jackson M.J."/>
<person name="Bentley D.R."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Dunham I."/>
</authorList>
<dbReference type="PubMed" id="15164053"/>
<dbReference type="DOI" id="10.1038/nature02465"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM IB)</scope>
<source>
<tissue>Cerebellum</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1987" name="Nature" volume="330" first="386" last="388">
<title>A new fused transcript in Philadelphia chromosome positive acute lymphocytic leukaemia.</title>
<authorList>
<person name="Fainstein E."/>
<person name="Marcelle C."/>
<person name="Rosner A."/>
<person name="Canaani E."/>
<person name="Gale R.P."/>
<person name="Dreazen O."/>
<person name="Smith S.D."/>
<person name="Croce C.M."/>
</authorList>
<dbReference type="PubMed" id="2825022"/>
<dbReference type="DOI" id="10.1038/330386a0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 27-40</scope>
<scope>SUBCELLULAR COMPONENT</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1983" name="Nature" volume="304" first="167" last="169">
<title>Homology between phosphotyrosine acceptor site of human c-abl and viral oncogene products.</title>
<authorList>
<person name="Groffen J."/>
<person name="Heisterkamp N."/>
<person name="Reynolds F.H. Jr."/>
<person name="Stephenson J.R."/>
</authorList>
<dbReference type="PubMed" id="6191223"/>
<dbReference type="DOI" id="10.1038/304167a0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE OF 360-426</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1994" name="Leukemia" volume="8" first="343" last="344">
<title>Sequence analysis of the mutation at codon 834 and the sequence variation of codon 837 of c-abl gene.</title>
<authorList>
<person name="Inokuchi K."/>
<person name="Futaki M."/>
<person name="Dan K."/>
<person name="Nomura T."/>
</authorList>
<dbReference type="PubMed" id="7545908"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 825-845</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1989" name="EMBO J." volume="8" first="449" last="456">
<title>N-terminal mutations activate the leukemogenic potential of the myristoylated form of c-abl.</title>
<authorList>
<person name="Jackson P."/>
<person name="Baltimore D."/>
</authorList>
<dbReference type="PubMed" id="2542016"/>
</citation>
<scope>MYRISTOYLATION AT GLY-2 (ISOFORM IB)</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1990" name="Science" volume="248" first="217" last="220">
<title>Differential phosphorylation of c-Abl in cell cycle determined by cdc2 kinase and phosphatase activity.</title>
<authorList>
<person name="Kipreos E.T."/>
<person name="Wang J.Y."/>
</authorList>
<dbReference type="PubMed" id="2183353"/>
<dbReference type="DOI" id="10.1126/science.2183353"/>
</citation>
<scope>DOMAIN</scope>
<scope>DNA-BINDING</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1997" name="Proc. Natl. Acad. Sci. U.S.A." volume="94" first="1437" last="1440">
<title>Regulation of DNA damage-induced apoptosis by the c-Abl tyrosine kinase.</title>
<authorList>
<person name="Yuan Z.M."/>
<person name="Huang Y."/>
<person name="Ishiko T."/>
<person name="Kharbanda S."/>
<person name="Weichselbaum R."/>
<person name="Kufe D."/>
</authorList>
<dbReference type="PubMed" id="9037071"/>
<dbReference type="DOI" id="10.1073/pnas.94.4.1437"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1997" name="Proc. Natl. Acad. Sci. U.S.A." volume="94" first="4954" last="4959">
<title>Protein binding and signaling properties of RIN1 suggest a unique effector function.</title>
<authorList>
<person name="Han L."/>
<person name="Wong D."/>
<person name="Dhaka A."/>
<person name="Afar D.E.H."/>
<person name="White M."/>
<person name="Xie W."/>
<person name="Herschman H."/>
<person name="Witte O."/>
<person name="Colicelli J."/>
</authorList>
<dbReference type="PubMed" id="9144171"/>
<dbReference type="DOI" id="10.1073/pnas.94.10.4954"/>
</citation>
<scope>INTERACTION WITH RIN1</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1998" name="J. Biol. Chem." volume="273" first="3799" last="3802">
<title>Regulation of Rad51 function by c-Abl in response to DNA damage.</title>
<authorList>
<person name="Yuan Z.M."/>
<person name="Huang Y."/>
<person name="Ishiko T."/>
<person name="Nakada S."/>
<person name="Utsugisawa T."/>
<person name="Kharbanda S."/>
<person name="Wang R."/>
<person name="Sung P."/>
<person name="Shinohara A."/>
<person name="Weichselbaum R."/>
<person name="Kufe D."/>
</authorList>
<dbReference type="PubMed" id="9461559"/>
<dbReference type="DOI" id="10.1074/jbc.273.7.3799"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH RAD51</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1999" name="Blood" volume="93" first="2707" last="2720">
<title>A novel SH2-containing phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase (SHIP2) is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene (SHC) in chronic myelogenous leukemia progenitor cells.</title>
<authorList>
<person name="Wisniewski D."/>
<person name="Strife A."/>
<person name="Swendeman S."/>
<person name="Erdjument-Bromage H."/>
<person name="Geromanos S."/>
<person name="Kavanaugh W.M."/>
<person name="Tempst P."/>
<person name="Clarkson B."/>
</authorList>
<dbReference type="PubMed" id="10194451"/>
</citation>
<scope>INTERACTION WITH INPPL1</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1999" name="Nature" volume="399" first="809" last="813">
<title>Interaction of c-Abl and p73alpha and their collaboration to induce apoptosis.</title>
<authorList>
<person name="Agami R."/>
<person name="Blandino G."/>
<person name="Oren M."/>
<person name="Shaul Y."/>
</authorList>
<dbReference type="PubMed" id="10391250"/>
<dbReference type="DOI" id="10.1038/21697"/>
</citation>
<scope>FUNCTION</scope>
<scope>ENZYME REGULATION</scope>
<scope>INTERACTION WITH TP73</scope>
</reference>
<reference key="18">
<citation type="journal article" date="1999" name="Nucleic Acids Res." volume="27" first="2265" last="2270">
<title>The DNA-binding domain of human c-Abl tyrosine kinase promotes the interaction of a HMG chromosomal protein with DNA.</title>
<authorList>
<person name="David-Cordonnier M.H."/>
<person name="Payet D."/>
<person name="D'Halluin J.C."/>
<person name="Waring M.J."/>
<person name="Travers A.A."/>
<person name="Bailly C."/>
</authorList>
<dbReference type="PubMed" id="10325413"/>
<dbReference type="DOI" id="10.1093/nar/27.11.2265"/>
</citation>
<scope>DNA-BINDING</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2000" name="Oncogene" volume="19" first="5643" last="5650">
<title>Regulation of cell death by the Abl tyrosine kinase.</title>
<authorList>
<person name="Wang J.Y."/>
</authorList>
<dbReference type="PubMed" id="11114745"/>
<dbReference type="DOI" id="10.1038/sj.onc.1203878"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2001" name="Genomics" volume="74" first="12" last="20">
<title>Cloning, mapping, and characterization of the human sorbin and SH3 domain containing 1 (SORBS1) gene: a protein associated with c-Abl during insulin signaling in the hepatoma cell line Hep3B.</title>
<authorList>
<person name="Lin W.-H."/>
<person name="Huang C.-J."/>
<person name="Liu M.-W."/>
<person name="Chang H.-M."/>
<person name="Chen Y.-J."/>
<person name="Tai T.-Y."/>
<person name="Chuang L.-M."/>
</authorList>
<dbReference type="PubMed" id="11374898"/>
<dbReference type="DOI" id="10.1006/geno.2001.6541"/>
</citation>
<scope>INTERACTION WITH SORBS1</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="48944" last="48948">
<title>Regulation of ionizing radiation-induced Rad52 nuclear foci formation by c-Abl-mediated phosphorylation.</title>
<authorList>
<person name="Kitao H."/>
<person name="Yuan Z.M."/>
</authorList>
<dbReference type="PubMed" id="12379650"/>
<dbReference type="DOI" id="10.1074/jbc.M208151200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH RAD52</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2002" name="Mol. Cell. Biol." volume="22" first="3292" last="3300">
<title>c-Abl tyrosine kinase regulates the human Rad9 checkpoint protein in response to DNA damage.</title>
<authorList>
<person name="Yoshida K."/>
<person name="Komatsu K."/>
<person name="Wang H.-G."/>
<person name="Kufe D."/>
</authorList>
<dbReference type="PubMed" id="11971963"/>
<dbReference type="DOI" id="10.1128/MCB.22.10.3292-3300.2002"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH RAD9A</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2003" name="Biochem. J." volume="370" first="29" last="34">
<title>Cbl-ArgBP2 complex mediates ubiquitination and degradation of c-Abl.</title>
<authorList>
<person name="Soubeyran P."/>
<person name="Barac A."/>
<person name="Szymkiewicz I."/>
<person name="Dikic I."/>
</authorList>
<dbReference type="PubMed" id="12475393"/>
<dbReference type="DOI" id="10.1042/BJ20021539"/>
</citation>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2003" name="Cell. Signal." volume="15" first="289" last="298">
<title>c-Abl is required for oxidative stress-induced phosphorylation of caveolin-1 on tyrosine 14.</title>
<authorList>
<person name="Sanguinetti A.R."/>
<person name="Mastick C.C."/>
</authorList>
<dbReference type="PubMed" id="12531427"/>
<dbReference type="DOI" id="10.1016/S0898-6568(02)00090-6"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="21685" last="21692">
<title>Abl interactor 1 promotes tyrosine 296 phosphorylation of mammalian enabled (Mena) by c-Abl kinase.</title>
<authorList>
<person name="Tani K."/>
<person name="Sato S."/>
<person name="Sukezane T."/>
<person name="Kojima H."/>
<person name="Hirose H."/>
<person name="Hanafusa H."/>
<person name="Shishido T."/>
</authorList>
<dbReference type="PubMed" id="12672821"/>
<dbReference type="DOI" id="10.1074/jbc.M301447200"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2003" name="J. Cell Sci." volume="116" first="2613" last="2626">
<title>Regulation of F-actin-dependent processes by the Abl family of tyrosine kinases.</title>
<authorList>
<person name="Woodring P.J."/>
<person name="Hunter T."/>
<person name="Wang J.Y."/>
</authorList>
<dbReference type="PubMed" id="12775773"/>
<dbReference type="DOI" id="10.1242/jcs.00622"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2004" name="Exp. Cell Res." volume="299" first="188" last="198">
<title>The c-Fes tyrosine kinase cooperates with the breakpoint cluster region protein (Bcr) to induce neurite extension in a Rac- and Cdc42-dependent manner.</title>
<authorList>
<person name="Laurent C.E."/>
<person name="Smithgall T.E."/>
</authorList>
<dbReference type="PubMed" id="15302586"/>
<dbReference type="DOI" id="10.1016/j.yexcr.2004.05.010"/>
</citation>
<scope>INTERACTION WITH BCR</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2004" name="FEBS Lett." volume="577" first="555" last="562">
<title>Catalytic domains of tyrosine kinases determine the phosphorylation sites within c-Cbl.</title>
<authorList>
<person name="Grossmann A.H."/>
<person name="Kolibaba K.S."/>
<person name="Willis S.G."/>
<person name="Corbin A.S."/>
<person name="Langdon W.S."/>
<person name="Deininger M.W."/>
<person name="Druker B.J."/>
</authorList>
<dbReference type="PubMed" id="15556646"/>
<dbReference type="DOI" id="10.1016/j.febslet.2004.10.054"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="22084" last="22091">
<title>The c-Abl tyrosine kinase phosphorylates the Fe65 adaptor protein to stimulate Fe65/amyloid precursor protein nuclear signaling.</title>
<authorList>
<person name="Perkinton M.S."/>
<person name="Standen C.L."/>
<person name="Lau K.F."/>
<person name="Kesavapany S."/>
<person name="Byers H.L."/>
<person name="Ward M."/>
<person name="McLoughlin D.M."/>
<person name="Miller C.C."/>
</authorList>
<dbReference type="PubMed" id="15031292"/>
<dbReference type="DOI" id="10.1074/jbc.M311479200"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2005" name="Cell Res." volume="15" first="33" last="35">
<title>Role of c-Abl in the DNA damage stress response.</title>
<authorList>
<person name="Shaul Y."/>
<person name="Ben-Yehoyada M."/>
</authorList>
<dbReference type="PubMed" id="15686624"/>
<dbReference type="DOI" id="10.1038/sj.cr.7290261"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2005" name="Curr. Biol." volume="15" first="815" last="823">
<title>RIN1 is an ABL tyrosine kinase activator and a regulator of epithelial-cell adhesion and migration.</title>
<authorList>
<person name="Hu H."/>
<person name="Bliss J.M."/>
<person name="Wang Y."/>
<person name="Colicelli J."/>
</authorList>
<dbReference type="PubMed" id="15886098"/>
<dbReference type="DOI" id="10.1016/j.cub.2005.03.049"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="11147" last="11151">
<title>c-Abl tyrosine kinase regulates caspase-9 autocleavage in the apoptotic response to DNA damage.</title>
<authorList>
<person name="Raina D."/>
<person name="Pandey P."/>
<person name="Ahmad R."/>
<person name="Bharti A."/>
<person name="Ren J."/>
<person name="Kharbanda S."/>
<person name="Weichselbaum R."/>
<person name="Kufe D."/>
</authorList>
<dbReference type="PubMed" id="15657060"/>
<dbReference type="DOI" id="10.1074/jbc.M413787200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH CASP9</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2005" name="Nat. Cell Biol." volume="7" first="278" last="285">
<title>JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting of c-Abl in the apoptotic response to DNA damage.</title>
<authorList>
<person name="Yoshida K."/>
<person name="Yamaguchi T."/>
<person name="Natsume T."/>
<person name="Kufe D."/>
<person name="Miki Y."/>
</authorList>
<dbReference type="PubMed" id="15696159"/>
<dbReference type="DOI" id="10.1038/ncb1228"/>
</citation>
<scope>INTERACTION WITH YWHAB; YWHAE; YWHAG; YWHAH; SFN AND YWHAZ</scope>
<scope>PHOSPHORYLATION AT THR-735</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF THR-735</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-569</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="35">
<citation type="journal article" date="2006" name="EMBO Rep." volume="7" first="727" last="733">
<title>c-Abl acetylation by histone acetyltransferases regulates its nuclear-cytoplasmic localization.</title>
<authorList>
<person name="di Bari M.G."/>
<person name="Ciuffini L."/>
<person name="Mingardi M."/>
<person name="Testi R."/>
<person name="Soddu S."/>
<person name="Barila D."/>
</authorList>
<dbReference type="PubMed" id="16648821"/>
<dbReference type="DOI" id="10.1038/sj.embor.7400700"/>
</citation>
<scope>ACETYLATION AT LYS-711</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="30907" last="30916">
<title>Src family kinases phosphorylate the Bcr-Abl SH3-SH2 region and modulate Bcr-Abl transforming activity.</title>
<authorList>
<person name="Meyn M.A. III"/>
<person name="Wilson M.B."/>
<person name="Abdi F.A."/>
<person name="Fahey N."/>
<person name="Schiavone A.P."/>
<person name="Wu J."/>
<person name="Hochrein J.M."/>
<person name="Engen J.R."/>
<person name="Smithgall T.E."/>
</authorList>
<dbReference type="PubMed" id="16912036"/>
<dbReference type="DOI" id="10.1074/jbc.M605902200"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-70; TYR-115; TYR-128; TYR-139; TYR-172; TYR-185 TYR-215; TYR-226 AND TYR-393</scope>
<scope>INTERACTION WITH HCK; LYN AND FYN</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="32714" last="32723">
<title>Abl tyrosine kinase regulates endocytosis of the epidermal growth factor receptor.</title>
<authorList>
<person name="Tanos B."/>
<person name="Pendergast A.M."/>
</authorList>
<dbReference type="PubMed" id="16943190"/>
<dbReference type="DOI" id="10.1074/jbc.M603126200"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2006" name="Mol. Cell" volume="22" first="317" last="327">
<title>Interaction between c-Abl and Arg tyrosine kinases and proteasome subunit PSMA7 regulates proteasome degradation.</title>
<authorList>
<person name="Liu X."/>
<person name="Huang W."/>
<person name="Li C."/>
<person name="Li P."/>
<person name="Yuan J."/>
<person name="Li X."/>
<person name="Qiu X.B."/>
<person name="Ma Q."/>
<person name="Cao C."/>
</authorList>
<dbReference type="PubMed" id="16678104"/>
<dbReference type="DOI" id="10.1016/j.molcel.2006.04.007"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH PSMA7</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2007" name="Curr. Biol." volume="17" first="445" last="451">
<title>A critical role for cortactin phosphorylation by Abl-family kinases in PDGF-induced dorsal-wave formation.</title>
<authorList>
<person name="Boyle S.N."/>
<person name="Michaud G.A."/>
<person name="Schweitzer B."/>
<person name="Predki P.F."/>
<person name="Koleske A.J."/>
</authorList>
<dbReference type="PubMed" id="17306540"/>
<dbReference type="DOI" id="10.1016/j.cub.2007.01.057"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="26257" last="26265">
<title>c-Abl-mediated phosphorylation of WAVE3 is required for lamellipodia formation and cell migration.</title>
<authorList>
<person name="Sossey-Alaoui K."/>
<person name="Li X."/>
<person name="Cowell J.K."/>
</authorList>
<dbReference type="PubMed" id="17623672"/>
<dbReference type="DOI" id="10.1074/jbc.M701484200"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH WASF3</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2008" name="Biochemistry" volume="47" first="1094" last="1104">
<title>Phosphorylation of c-Abl by protein kinase Pak2 regulates differential binding of ABI2 and CRK.</title>
<authorList>
<person name="Jung J.H."/>
<person name="Pendergast A.M."/>
<person name="Zipfel P.A."/>
<person name="Traugh J.A."/>
</authorList>
<dbReference type="PubMed" id="18161990"/>
<dbReference type="DOI" id="10.1021/bi701533j"/>
</citation>
<scope>PHOSPHORYLATION AT SER-618 AND SER-619</scope>
<scope>INTERACTION WITH ABI2 AND CRK</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2008" name="Biochim. Biophys. Acta" volume="1783" first="737" last="747">
<title>Allosteric inhibition of the nonMyristoylated c-Abl tyrosine kinase by phosphopeptides derived from Abi1/Hssh3bp1.</title>
<authorList>
<person name="Xiong X."/>
<person name="Cui P."/>
<person name="Hossain S."/>
<person name="Xu R."/>
<person name="Warner B."/>
<person name="Guo X."/>
<person name="An X."/>
<person name="Debnath A.K."/>
<person name="Cowburn D."/>
<person name="Kotula L."/>
</authorList>
<dbReference type="PubMed" id="18328268"/>
<dbReference type="DOI" id="10.1016/j.bbamcr.2008.01.028"/>
</citation>
<scope>FUNCTION</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2008" name="J. Biol. Chem." volume="283" first="35941" last="35953">
<title>Abl kinases regulate autophagy by promoting the trafficking and function of lysosomal components.</title>
<authorList>
<person name="Yogalingam G."/>
<person name="Pendergast A.M."/>
</authorList>
<dbReference type="PubMed" id="18945674"/>
<dbReference type="DOI" id="10.1074/jbc.M804543200"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2008" name="J. Mol. Biol." volume="383" first="414" last="423">
<title>Tyrosine phosphorylation in the SH3 domain disrupts negative regulatory interactions within the c-Abl kinase core.</title>
<authorList>
<person name="Chen S."/>
<person name="O'Reilly L.P."/>
<person name="Smithgall T.E."/>
<person name="Engen J.R."/>
</authorList>
<dbReference type="PubMed" id="18775435"/>
<dbReference type="DOI" id="10.1016/j.jmb.2008.08.040"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-70</scope>
<scope>INTERACTION WITH ABI1</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-50; SER-569; SER-659; THR-814; THR-844 AND SER-977</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="46">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-569; THR-852 AND SER-917</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="47">
<citation type="journal article" date="2008" name="Trends Biochem. Sci." volume="33" first="80" last="90">
<title>Emerging roles of Abl family tyrosine kinases in microbial pathogenesis.</title>
<authorList>
<person name="Backert S."/>
<person name="Feller S.M."/>
<person name="Wessler S."/>
</authorList>
<dbReference type="PubMed" id="18182299"/>
<dbReference type="DOI" id="10.1016/j.tibs.2007.10.006"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2009" name="BMC Cell Biol." volume="10" first="80" last="80">
<title>Cbl-associated protein is tyrosine phosphorylated by c-Abl and c-Src kinases.</title>
<authorList>
<person name="Fernow I."/>
<person name="Tomasovic A."/>
<person name="Siehoff-Icking A."/>
<person name="Tikkanen R."/>
</authorList>
<dbReference type="PubMed" id="19891780"/>
<dbReference type="DOI" id="10.1186/1471-2121-10-80"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.M800588-MCP200"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-569</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2009" name="PLoS ONE" volume="4" first="E5211" last="E5211">
<title>Unc119 protects from Shigella infection by inhibiting the Abl family kinases.</title>
<authorList>
<person name="Vepachedu R."/>
<person name="Karim Z."/>
<person name="Patel O."/>
<person name="Goplen N."/>
<person name="Alam R."/>
</authorList>
<dbReference type="PubMed" id="19381274"/>
<dbReference type="DOI" id="10.1371/journal.pone.0005211"/>
</citation>
<scope>IDENTIFICATION IN A COMPLEX WITH UNC119; ABL2 AND CRK</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-50 AND SER-569</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="53">
<citation type="journal article" date="2010" name="Curr. Biol." volume="20" first="783" last="791">
<title>c-Abl, Lamellipodin, and Ena/VASP proteins cooperate in dorsal ruffling of fibroblasts and axonal morphogenesis.</title>
<authorList>
<person name="Michael M."/>
<person name="Vehlow A."/>
<person name="Navarro C."/>
<person name="Krause M."/>
</authorList>
<dbReference type="PubMed" id="20417104"/>
<dbReference type="DOI" id="10.1016/j.cub.2010.03.048"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2010" name="Mol. Biol. Cell" volume="21" first="4042" last="4056">
<title>Abl tyrosine kinase phosphorylates nonmuscle Myosin light chain kinase to regulate endothelial barrier function.</title>
<authorList>
<person name="Dudek S.M."/>
<person name="Chiang E.T."/>
<person name="Camp S.M."/>
<person name="Guo Y."/>
<person name="Zhao J."/>
<person name="Brown M.E."/>
<person name="Singleton P.A."/>
<person name="Wang L."/>
<person name="Desai A."/>
<person name="Arce F.T."/>
<person name="Lal R."/>
<person name="Van Eyk J.E."/>
<person name="Imam S.Z."/>
<person name="Garcia J.G.N."/>
</authorList>
<dbReference type="PubMed" id="20861316"/>
<dbReference type="DOI" id="10.1091/mbc.E09-10-0876"/>
</citation>
<scope>INTERACTION WITH MYLK AND CTTN</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RE6" last="RE6">
<title>ABL tyrosine kinases: evolution of function, regulation, and specificity.</title>
<authorList>
<person name="Colicelli J."/>
</authorList>
<dbReference type="PubMed" id="20841568"/>
<dbReference type="DOI" id="10.1126/scisignal.3139re6"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2012" name="Biochim. Biophys. Acta" volume="1823" first="2109" last="2119">
<title>Tyrosine phosphorylation of a SNARE protein, Syntaxin 17: Implications for membrane trafficking in the early secretory pathway.</title>
<authorList>
<person name="Muppirala M."/>
<person name="Gupta V."/>
<person name="Swarup G."/>
</authorList>
<dbReference type="PubMed" id="23006999"/>
<dbReference type="DOI" id="10.1016/j.bbamcr.2012.09.003"/>
</citation>
<scope>INTERACTION WITH STX17</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-253; TYR-257; TYR-413; SER-559; SER-569; SER-620; SER-683; SER-718; THR-751; THR-781; THR-823; THR-844; THR-852; SER-855 AND SER-917</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="59">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-569</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="60">
<citation type="journal article" date="2017" name="Sci. Rep." volume="7" first="887" last="887">
<title>Differential regulation of PKD isoforms in oxidative stress conditions through phosphorylation of a conserved Tyr in the P+1 loop.</title>
<authorList>
<person name="Cobbaut M."/>
<person name="Derua R."/>
<person name="Doeppler H."/>
<person name="Lou H.J."/>
<person name="Vandoninck S."/>
<person name="Storz P."/>
<person name="Turk B.E."/>
<person name="Seufferlein T."/>
<person name="Waelkens E."/>
<person name="Janssens V."/>
<person name="Van Lint J."/>
</authorList>
<dbReference type="PubMed" id="28428613"/>
<dbReference type="DOI" id="10.1038/s41598-017-00800-w"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="61">
<citation type="journal article" date="1992" name="Cell" volume="70" first="697" last="704">
<title>Three-dimensional solution structure of the src homology 2 domain of c-abl.</title>
<authorList>
<person name="Overduin M."/>
<person name="Rios C.B."/>
<person name="Mayer B.J."/>
<person name="Baltimore D."/>
<person name="Cowburn D."/>
</authorList>
<dbReference type="PubMed" id="1505033"/>
<dbReference type="DOI" id="10.1016/0092-8674(92)90437-H"/>
</citation>
<scope>STRUCTURE BY NMR OF SH2 DOMAIN</scope>
</reference>
<reference key="62">
<citation type="journal article" date="1992" name="Proc. Natl. Acad. Sci. U.S.A." volume="89" first="11673" last="11677">
<title>Secondary structure of Src homology 2 domain of c-Abl by heteronuclear NMR spectroscopy in solution.</title>
<authorList>
<person name="Overduin M."/>
<person name="Mayer B.J."/>
<person name="Rios C.B."/>
<person name="Baltimore D."/>
<person name="Cowburn D."/>
</authorList>
<dbReference type="PubMed" id="1281542"/>
<dbReference type="DOI" id="10.1073/pnas.89.24.11673"/>
</citation>
<scope>STRUCTURE BY NMR OF SH2 DOMAIN</scope>
</reference>
<reference key="63">
<citation type="journal article" date="1994" name="Proteins" volume="20" first="203" last="215">
<title>Homology modeling of the Abl-SH3 domain.</title>
<authorList>
<person name="Pisabarro M.T."/>
<person name="Ortiz A.R."/>
<person name="Serrano L."/>
<person name="Wade R.C."/>
</authorList>
<dbReference type="PubMed" id="7892170"/>
<dbReference type="DOI" id="10.1002/prot.340200302"/>
</citation>
<scope>3D-STRUCTURE MODELING OF SH3 DOMAIN</scope>
</reference>
<reference key="64">
<citation type="journal article" date="1995" name="Structure" volume="3" first="1075" last="1086">
<title>The solution structure of Abl SH3, and its relationship to SH2 in the SH(32) construct.</title>
<authorList>
<person name="Gosser Y.Q."/>
<person name="Zheng J."/>
<person name="Overduin M."/>
<person name="Mayer B.J."/>
<person name="Cowburn D."/>
</authorList>
<dbReference type="PubMed" id="8590002"/>
<dbReference type="DOI" id="10.1016/S0969-2126(01)00243-X"/>
</citation>
<scope>STRUCTURE BY NMR OF SH3 DOMAIN</scope>
</reference>
<reference key="65">
<citation type="journal article" date="1998" name="J. Mol. Biol." volume="281" first="513" last="521">
<title>Crystal structure of the abl-SH3 domain complexed with a designed high-affinity peptide ligand: implications for SH3-ligand interactions.</title>
<authorList>
<person name="Pisabarro M.T."/>
<person name="Serrano L."/>
<person name="Wilmanns M."/>
</authorList>
<dbReference type="PubMed" id="9698566"/>
<dbReference type="DOI" id="10.1006/jmbi.1998.1932"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.65 ANGSTROMS) OF 64-121</scope>
</reference>
<reference key="66">
<citation type="journal article" date="2002" name="Proc. Natl. Acad. Sci. U.S.A." volume="99" first="14053" last="14058">
<title>Structure of a regulatory complex involving the Abl SH3 domain, the Crk SH2 domain, and a Crk-derived phosphopeptide.</title>
<authorList>
<person name="Donaldson L.W."/>
<person name="Gish G."/>
<person name="Pawson T."/>
<person name="Kay L.E."/>
<person name="Forman-Kay J.D."/>
</authorList>
<dbReference type="PubMed" id="12384576"/>
<dbReference type="DOI" id="10.1073/pnas.212518799"/>
</citation>
<scope>STRUCTURE BY NMR OF 62-122 IN COMPLEX WITH CRK</scope>
</reference>
<reference key="67">
<citation type="journal article" date="2003" name="Cell" volume="112" first="859" last="871">
<title>Structural basis for the autoinhibition of c-Abl tyrosine kinase.</title>
<authorList>
<person name="Nagar B."/>
<person name="Hantschel O."/>
<person name="Young M.A."/>
<person name="Scheffzek K."/>
<person name="Veach D."/>
<person name="Bornmann W."/>
<person name="Clarkson B."/>
<person name="Superti-Furga G."/>
<person name="Kuriyan J."/>
</authorList>
<dbReference type="PubMed" id="12654251"/>
<dbReference type="DOI" id="10.1016/S0092-8674(03)00194-6"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.42 ANGSTROMS) OF 27-512</scope>
<scope>MYRISTOYLATION AT GLY-2 (ISOFORM IB)</scope>
<scope>ENZYME REGULATION</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="68">
<citation type="journal article" date="2006" name="Cancer Res." volume="66" first="1007" last="1014">
<title>Structure of the kinase domain of an imatinib-resistant Abl mutant in complex with the Aurora kinase inhibitor VX-680.</title>
<authorList>
<person name="Young M.A."/>
<person name="Shah N.P."/>
<person name="Chao L.H."/>
<person name="Seeliger M."/>
<person name="Milanov Z.V."/>
<person name="Biggs W.H. III"/>
<person name="Treiber D.K."/>
<person name="Patel H.K."/>
<person name="Zarrinkar P.P."/>
<person name="Lockhart D.J."/>
<person name="Sawyers C.L."/>
<person name="Kuriyan J."/>
</authorList>
<dbReference type="PubMed" id="16424036"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-05-2788"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.91 ANGSTROMS) OF 229-513 OF MUTANT PRO-396 IN COMPLEX WITH INHIBITOR VX-680</scope>
<scope>FUNCTION</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="69">
<citation type="journal article" date="2006" name="Mol. Cell" volume="21" first="787" last="798">
<title>Organization of the SH3-SH2 unit in active and inactive forms of the c-Abl tyrosine kinase.</title>
<authorList>
<person name="Nagar B."/>
<person name="Hantschel O."/>
<person name="Seeliger M."/>
<person name="Davies J.M."/>
<person name="Weis W.I."/>
<person name="Superti-Furga G."/>
<person name="Kuriyan J."/>
</authorList>
<dbReference type="PubMed" id="16543148"/>
<dbReference type="DOI" id="10.1016/j.molcel.2006.01.035"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.27 ANGSTROMS) OF 38-512</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>MYRISTOYLATION AT GLY-2 (ISOFORM IB)</scope>
<scope>PHOSPHORYLATION AT SER-50</scope>
<scope>AUTOINHIBITORY MECHANISM</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="70">
<citation type="journal article" date="2006" name="PLoS Biol." volume="4" first="E144" last="E144">
<title>A Src-like inactive conformation in the abl tyrosine kinase domain.</title>
<authorList>
<person name="Levinson N.M."/>
<person name="Kuchment O."/>
<person name="Shen K."/>
<person name="Young M.A."/>
<person name="Koldobskiy M."/>
<person name="Karplus M."/>
<person name="Cole P.A."/>
<person name="Kuriyan J."/>
</authorList>
<dbReference type="PubMed" id="16640460"/>
<dbReference type="DOI" id="10.1371/journal.pbio.0040144"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 229-512 IN COMPLEXES WITH ATP-PEPTIDE CONJUGATE</scope>
<scope>CONFORMATION CHANGES DURING ACTIVATION</scope>
</reference>
<reference key="71">
<citation type="journal article" date="2007" name="Acta Crystallogr. D" volume="63" first="80" last="93">
<title>Structural biology contributions to the discovery of drugs to treat chronic myelogenous leukaemia.</title>
<authorList>
<person name="Cowan-Jacob S.W."/>
<person name="Fendrich G."/>
<person name="Floersheimer A."/>
<person name="Furet P."/>
<person name="Liebetanz J."/>
<person name="Rummel G."/>
<person name="Rheinberger P."/>
<person name="Centeleghe M."/>
<person name="Fabbro D."/>
<person name="Manley P.W."/>
</authorList>
<dbReference type="PubMed" id="17164530"/>
<dbReference type="DOI" id="10.1107/S0907444906047287"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 229-500 IN COMPLEXES WITH IMATINIB AND WITH THE INHIBITORS NVP-AEG082; NVP-AFN941; NVP-AFG210 AND PD180970</scope>
</reference>
<reference key="72">
<citation type="journal article" date="2007" name="Acta Crystallogr. D" volume="63" first="646" last="652">
<title>Crystallization by capillary counter-diffusion and structure determination of the N114A mutant of the SH3 domain of Abl tyrosine kinase complexed with a high-affinity peptide ligand.</title>
<authorList>
<person name="Camara-Artigas A."/>
<person name="Palencia A."/>
<person name="Martinez J.C."/>
<person name="Luque I."/>
<person name="Gavira J.A."/>
<person name="Garcia-Ruiz J.M."/>
</authorList>
<dbReference type="PubMed" id="17452790"/>
<dbReference type="DOI" id="10.1107/S0907444907011109"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 64-121 OF MUTANT ALA-114 IN COMPLEX WITH PROLINE-RICH PEPTIDE</scope>
</reference>
<reference key="73">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="2823" last="2833">
<title>Role of interfacial water molecules in proline-rich ligand recognition by the Src homology 3 domain of Abl.</title>
<authorList>
<person name="Palencia A."/>
<person name="Camara-Artigas A."/>
<person name="Pisabarro M.T."/>
<person name="Martinez J.C."/>
<person name="Luque I."/>
</authorList>
<dbReference type="PubMed" id="19906645"/>
<dbReference type="DOI" id="10.1074/jbc.M109.048033"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.4 ANGSTROMS) OF 60-121 IN COMPLEX WITH PROLINE-RICH PEPTIDE P41</scope>
</reference>
<reference key="74">
<citation type="journal article" date="2010" name="Nat. Struct. Mol. Biol." volume="17" first="519" last="527">
<title>A potent and highly specific FN3 monobody inhibitor of the Abl SH2 domain.</title>
<authorList>
<person name="Wojcik J."/>
<person name="Hantschel O."/>
<person name="Grebien F."/>
<person name="Kaupe I."/>
<person name="Bennett K.L."/>
<person name="Barkinge J."/>
<person name="Jones R.B."/>
<person name="Koide A."/>
<person name="Superti-Furga G."/>
<person name="Koide S."/>
</authorList>
<dbReference type="PubMed" id="20357770"/>
<dbReference type="DOI" id="10.1038/nsmb.1793"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 121-232 IN COMPLEX WITH ANTIBODY MIMIC HA4</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="75">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS GLY-47; LYS-166; VAL-706; LEU-810 AND LEU-972</scope>
</reference>
<reference key="76">
<citation type="journal article" date="2017" name="Nat. Genet." volume="49" first="613" last="617">
<title>Germline mutations in ABL1 cause an autosomal dominant syndrome characterized by congenital heart defects and skeletal malformations.</title>
<authorList>
<person name="Wang X."/>
<person name="Charng W.L."/>
<person name="Chen C.A."/>
<person name="Rosenfeld J.A."/>
<person name="Al Shamsi A."/>
<person name="Al-Gazali L."/>
<person name="McGuire M."/>
<person name="Mew N.A."/>
<person name="Arnold G.L."/>
<person name="Qu C."/>
<person name="Ding Y."/>
<person name="Muzny D.M."/>
<person name="Gibbs R.A."/>
<person name="Eng C.M."/>
<person name="Walkiewicz M."/>
<person name="Xia F."/>
<person name="Plon S.E."/>
<person name="Lupski J.R."/>
<person name="Schaaf C.P."/>
<person name="Yang Y."/>
</authorList>
<dbReference type="PubMed" id="28288113"/>
<dbReference type="DOI" id="10.1038/ng.3815"/>
</citation>
<scope>INVOLVEMENT IN CHDSKM</scope>
<scope>VARIANTS CHDSKM CYS-226 AND THR-337</scope>
<scope>CHARACTERIZATION OF VARIANTS CHDSKM CYS-226 AND THR-337</scope>
</reference>
<comment type="function">
<text evidence="25 33 35 36 39 41 42 44 45 47 48 51 53 54 57 59 61 63 65 66 70 72 73 74">Non-receptor tyrosine-protein kinase that plays a role in many key processes linked to cell growth and survival such as cytoskeleton remodeling in response to extracellular stimuli, cell motility and adhesion, receptor endocytosis, autophagy, DNA damage response and apoptosis. Coordinates actin remodeling through tyrosine phosphorylation of proteins controlling cytoskeleton dynamics like WASF3 (involved in branch formation); ANXA1 (involved in membrane anchoring); DBN1, DBNL, CTTN, RAPH1 and ENAH (involved in signaling); or MAPT and PXN (microtubule-binding proteins). Phosphorylation of WASF3 is critical for the stimulation of lamellipodia formation and cell migration. Involved in the regulation of cell adhesion and motility through phosphorylation of key regulators of these processes such as BCAR1, CRK, CRKL, DOK1, EFS or NEDD9. Phosphorylates multiple receptor tyrosine kinases and more particularly promotes endocytosis of EGFR, facilitates the formation of neuromuscular synapses through MUSK, inhibits PDGFRB-mediated chemotaxis and modulates the endocytosis of activated B-cell receptor complexes. Other substrates which are involved in endocytosis regulation are the caveolin (CAV1) and RIN1. Moreover, ABL1 regulates the CBL family of ubiquitin ligases that drive receptor down-regulation and actin remodeling. Phosphorylation of CBL leads to increased EGFR stability. Involved in late-stage autophagy by regulating positively the trafficking and function of lysosomal components. ABL1 targets to mitochondria in response to oxidative stress and thereby mediates mitochondrial dysfunction and cell death. In response to oxidative stress, phosphorylates serine/threonine kinase PRKD2 at 'Tyr-717' (PubMed:28428613). ABL1 is also translocated in the nucleus where it has DNA-binding activity and is involved in DNA-damage response and apoptosis. Many substrates are known mediators of DNA repair: DDB1, DDB2, ERCC3, ERCC6, RAD9A, RAD51, RAD52 or WRN. Activates the proapoptotic pathway when the DNA damage is too severe to be repaired. Phosphorylates TP73, a primary regulator for this type of damage-induced apoptosis. Phosphorylates the caspase CASP9 on 'Tyr-153' and regulates its processing in the apoptotic response to DNA damage. Phosphorylates PSMA7 that leads to an inhibition of proteasomal activity and cell cycle transition blocks. ABL1 acts also as a regulator of multiple pathological signaling cascades during infection. Several known tyrosine-phosphorylated microbial proteins have been identified as ABL1 substrates. This is the case of A36R of Vaccinia virus, Tir (translocated intimin receptor) of pathogenic E.coli and possibly Citrobacter, CagA (cytotoxin-associated gene A) of H.pylori, or AnkA (ankyrin repeat-containing protein A) of A.phagocytophilum. Pathogens can highjack ABL1 kinase signaling to reorganize the host actin cytoskeleton for multiple purposes, like facilitating intracellular movement and host cell exit. Finally, functions as its own regulator through autocatalytic activity as well as through phosphorylation of its inhibitor, ABI1. Regulates T-cell differentiation in a TBX21-dependent manner. Phosphorylates TBX21 on tyrosine residues leading to an enhancement of its transcriptional activator activity (By similarity).</text>
</comment>
<comment type="catalytic activity">
<text evidence="31 65 70">ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.</text>
</comment>
<comment type="cofactor">
<cofactor evidence="25">
<name>Mg(2+)</name>
<dbReference type="ChEBI" id="CHEBI:18420"/>
</cofactor>
</comment>
<comment type="enzyme regulation">
<text evidence="24 33 40 48 49 59 70">Stabilized in the inactive form by an association between the SH3 domain and the SH2-TK linker region, interactions of the N-terminal cap, and contributions from an N-terminal myristoyl group and phospholipids. Activated by autophosphorylation as well as by SRC-family kinase-mediated phosphorylation. Activated by RIN1 binding to the SH2 and SH3 domains. Also stimulated by cell death inducers and DNA-damage. Phosphatidylinositol 4,5-bisphosphate (PIP2), a highly abundant phosphoinositide known to regulate cytoskeletal and membrane proteins, inhibits also the tyrosine kinase activity (By similarity). Activated by 5-(1,3-diaryl-1H-pyrazol-4-yl)hydantoin, 5-[3-(4-fluorophenyl)-1-phenyl-1H-pyrazol-4-yl]-2,4-imidazolidinedione (DPH) (PubMed:28428613). Inhibited by ABI1, whose activity is controlled by ABL1 itself through tyrosine phosphorylation. Also inhibited by imatinib mesylate (Gleevec) which is used for the treatment of chronic myeloid leukemia (CML), and by VX-680, an inhibitor that acts also on imatinib-resistant mutants (PubMed:28428613).</text>
</comment>
<comment type="subunit">
<text evidence="25 32 33 34 35 36 37 43 45 46 48 51 52 56 57 58 60 62 64 65 67 68 73 74">Interacts with SORBS1 following insulin stimulation. Found in a trimolecular complex containing CDK5 and CABLES1. Interacts with CABLES1 and PSTPIP1. Interacts with ZDHHC16, ITGB1 and HCK (By similarity). Interacts with STX17; probably phosphorylates STX17. Interacts with INPPL1/SHIP2. Interacts with the 14-3-3 proteins, YWHAB, YWHAE, YWHAG, YWHAH, SFN AND YWHAZ; the interaction with 14-3-3 proteins requires phosphorylation on Thr-735 and, sequesters ABL1 into the cytoplasm. Interacts with ABI1, ABI2, BCR, CRK, FGR, FYN, HCK, LYN, PSMA7 RAD9A, RAD51, RAD52, TP73 and WASF3. A complex made of ABL1, CTTN and MYLK regulates cortical actin-based cytoskeletal rearrangement critical to sphingosine 1-phosphate (S1P)-mediated endothelial cell (EC) barrier enhancement. Interacts (via SH3 domain) with CASP9; the interaction is direct and increases in the response of cells to genotoxic stress and ABL1/c-Abl activation. Found in a complex with ABL1, ABL2, CRK and UNC119; leading to the inhibition of CRK phosphorylation by ABL kinases. Interacts with TBX21 (By similarity).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375543"/>
<interactant intactId="EBI-375446">
<id>Q8IZP0</id>
<label>ABI1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375543"/>
<interactant intactId="EBI-743598">
<id>Q9NYB9</id>
<label>ABI2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375543"/>
<interactant intactId="EBI-608057">
<id>P10275</id>
<label>AR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375543"/>
<interactant intactId="EBI-495465">
<id>Q13315</id>
<label>ATM</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375543"/>
<interactant intactId="EBI-7016840">
<id>Q4KMG0</id>
<label>CDON</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375543"/>
<interactant intactId="EBI-7016767">
<id>O35158</id>
<label>Cdon</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375543"/>
<interactant intactId="EBI-886">
<id>P46108</id>
<label>CRK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375543"/>
<interactant intactId="EBI-910">
<id>P46109</id>
<label>CRKL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375543"/>
<interactant intactId="EBI-491549">
<id>P35222</id>
<label>CTNNB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375543"/>
<interactant intactId="EBI-297353">
<id>P00533</id>
<label>EGFR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375543"/>
<interactant intactId="EBI-641062">
<id>P04626</id>
<label>ERBB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375543"/>
<interactant intactId="EBI-489954">
<id>Q14315</id>
<label>FLNC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375543"/>
<interactant intactId="EBI-300173">
<id>P05107</id>
<label>ITGB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375543"/>
<interactant intactId="EBI-1379503">
<id>P10721</id>
<label>KIT</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375543"/>
<interactant intactId="EBI-1050422">
<id>Q38SD2</id>
<label>LRRK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375543"/>
<interactant intactId="EBI-881">
<id>Q92918</id>
<label>MAP4K1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375543"/>
<interactant intactId="EBI-995373">
<id>Q7Z434</id>
<label>MAVS</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375543"/>
<interactant intactId="EBI-6092730">
<id>O43196</id>
<label>MSH5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375543"/>
<interactant intactId="EBI-2804728">
<id>P15941</id>
<label>MUC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375543"/>
<interactant intactId="EBI-389883">
<id>P16333</id>
<label>NCK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375543"/>
<interactant intactId="EBI-1751761">
<id>O43900</id>
<label>PRICKLE3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375543"/>
<interactant intactId="EBI-976876">
<id>Q13905</id>
<label>RAPGEF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375543"/>
<interactant intactId="EBI-1043236">
<id>Q86UR5</id>
<label>RIMS1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375543"/>
<interactant intactId="EBI-366017">
<id>Q13671</id>
<label>RIN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375543"/>
<interactant intactId="EBI-476295">
<id>P31947</id>
<label>SFN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375543"/>
<interactant intactId="EBI-4402156">
<id>Q15464</id>
<label>SHB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375543"/>
<interactant intactId="EBI-1752674">
<id>O75751</id>
<label>SLC22A3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-5278159"/>
<interactant intactId="EBI-985879">
<id>P37840</id>
<label>SNCA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375543"/>
<interactant intactId="EBI-433642">
<id>Q9BX66</id>
<label>SORBS1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375543"/>
<interactant intactId="EBI-1222956">
<id>O60504-2</id>
<label>SORBS3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375543"/>
<interactant intactId="EBI-298181">
<id>Q07890</id>
<label>SOS2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375543"/>
<interactant intactId="EBI-621482">
<id>P12931</id>
<label>SRC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375543"/>
<interactant intactId="EBI-1220811">
<id>Q9Y4G6</id>
<label>TLN2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375543"/>
<interactant intactId="EBI-876302">
<id>P11387</id>
<label>TOP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375543"/>
<interactant intactId="EBI-625518">
<id>P15498</id>
<label>VAV1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375543"/>
<interactant intactId="EBI-347088">
<id>P63104</id>
<label>YWHAZ</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cytoplasm</location>
<location>cytoskeleton</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="24">Mitochondrion</location>
</subcellularLocation>
<text evidence="24">Shuttles between the nucleus and cytoplasm depending on environmental signals. Sequestered into the cytoplasm through interaction with 14-3-3 proteins. Localizes to mitochondria in response to oxidative stress (By similarity).</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform IB</molecule>
<subcellularLocation>
<location>Nucleus membrane</location>
<topology>Lipid-anchor</topology>
</subcellularLocation>
<text>The myristoylated c-ABL protein is reported to be nuclear.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P00519-1</id>
<name>IA</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P00519-2</id>
<name>IB</name>
<sequence type="described" ref="VSP_004957"/>
<text>Contains a N-myristoyl glycine at position 2.</text>
</isoform>
</comment>
<comment type="tissue specificity">
<text>Widely expressed.</text>
</comment>
<comment type="PTM">
<text evidence="50">Acetylated at Lys-711 by EP300 which promotes the cytoplasmic translocation.</text>
</comment>
<comment type="PTM">
<text evidence="24">Phosphorylation at Tyr-70 by members of the SRC family of kinases disrupts SH3 domain-based autoinhibitory interactions and intermolecular associations, such as that with ABI1, and also enhances kinase activity. Phosphorylation at Tyr-226 and Tyr-393 correlate with increased activity. DNA damage-induced activation of ABL1 requires the function of ATM and Ser-446 phosphorylation (By similarity). Phosphorylation at Ser-569 has been attributed to a CDC2-associated kinase and is coupled to cell division (By similarity). Phosphorylation at Ser-618 and Ser-619 by PAK2 increases binding to CRK and reduces binding to ABI1. Phosphorylation on Thr-735 is required for binding 14-3-3 proteins for cytoplasmic translocation. Phosphorylated by PRKDC (By similarity).</text>
</comment>
<comment type="PTM">
<text evidence="38">Polyubiquitinated. Polyubiquitination of ABL1 leads to degradation.</text>
</comment>
<comment type="disease">
<disease id="DI-03735">
<name>Leukemia, chronic myeloid</name>
<acronym>CML</acronym>
<description>A clonal myeloproliferative disorder of a pluripotent stem cell with a specific cytogenetic abnormality, the Philadelphia chromosome (Ph), involving myeloid, erythroid, megakaryocytic, B-lymphoid, and sometimes T-lymphoid cells, but not marrow fibroblasts.</description>
<dbReference type="MIM" id="608232"/>
</disease>
<text>The gene represented in this entry is involved in disease pathogenesis.</text>
</comment>
<comment type="disease">
<text>A chromosomal aberration involving ABL1 has been found in patients with chronic myeloid leukemia. Translocation t(9;22)(q34;q11) with BCR. The translocation produces a BCR-ABL found also in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).</text>
</comment>
<comment type="disease" evidence="69">
<disease id="DI-05064">
<name>Congenital heart defects and skeletal malformations syndrome</name>
<acronym>CHDSKM</acronym>
<description>An autosomal dominant disorder characterized by congenital heart disease with atrial and ventricular septal defects, variable skeletal abnormalities, and failure to thrive. Skeletal defects include pectus excavatum, scoliosis, and finger contractures. Some patient exhibit joint laxity.</description>
<dbReference type="MIM" id="617602"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="28">Belongs to the protein kinase superfamily. Tyr protein kinase family. ABL subfamily.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/ABLID1.html"/>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/abl1/"/>
</comment>
<dbReference type="EC" id="2.7.10.2" evidence="65 70"/>
<dbReference type="EMBL" id="M14752">
<property type="protein sequence ID" value="AAA51561.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X16416">
<property type="protein sequence ID" value="CAA34438.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U07563">
<property type="protein sequence ID" value="AAB60394.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U07563">
<property type="protein sequence ID" value="AAB60393.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U07561">
<property type="protein sequence ID" value="AAB60393.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ145721">
<property type="protein sequence ID" value="AAZ38718.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL359092">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL161733">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471090">
<property type="protein sequence ID" value="EAW87948.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC117451">
<property type="protein sequence ID" value="AAI17452.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="S69223">
<property type="protein sequence ID" value="AAD14034.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS35165.1">
<molecule id="P00519-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS35166.1">
<molecule id="P00519-1"/>
</dbReference>
<dbReference type="PIR" id="S08519">
<property type="entry name" value="TVHUA"/>
</dbReference>
<dbReference type="RefSeq" id="NP_005148.2">
<molecule id="P00519-1"/>
<property type="nucleotide sequence ID" value="NM_005157.5"/>
</dbReference>
<dbReference type="RefSeq" id="NP_009297.2">
<molecule id="P00519-2"/>
<property type="nucleotide sequence ID" value="NM_007313.2"/>
</dbReference>
<dbReference type="UniGene" id="Hs.431048"/>
<dbReference type="PDB" id="1AB2">
<property type="method" value="NMR"/>
<property type="chains" value="A=120-220"/>
</dbReference>
<dbReference type="PDB" id="1ABL">
<property type="method" value="Model"/>
<property type="chains" value="A=65-121"/>
</dbReference>
<dbReference type="PDB" id="1AWO">
<property type="method" value="NMR"/>
<property type="chains" value="A=65-119"/>
</dbReference>
<dbReference type="PDB" id="1BBZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.65"/>
<property type="chains" value="A/C/E/G=64-121"/>
</dbReference>
<dbReference type="PDB" id="1JU5">
<property type="method" value="NMR"/>
<property type="chains" value="C=62-122"/>
</dbReference>
<dbReference type="PDB" id="1OPL">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.42"/>
<property type="chains" value="A/B=27-512"/>
</dbReference>
<dbReference type="PDB" id="1ZZP">
<property type="method" value="NMR"/>
<property type="chains" value="A=1007-1130"/>
</dbReference>
<dbReference type="PDB" id="2ABL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=57-218"/>
</dbReference>
<dbReference type="PDB" id="2E2B">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A/B=229-515"/>
</dbReference>
<dbReference type="PDB" id="2F4J">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.91"/>
<property type="chains" value="A=229-513"/>
</dbReference>
<dbReference type="PDB" id="2FO0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.27"/>
<property type="chains" value="A=38-512"/>
</dbReference>
<dbReference type="PDB" id="2G1T">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A/B/C/D=229-512"/>
</dbReference>
<dbReference type="PDB" id="2G2F">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/B=229-512"/>
</dbReference>
<dbReference type="PDB" id="2G2H">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/B=229-512"/>
</dbReference>
<dbReference type="PDB" id="2G2I">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.12"/>
<property type="chains" value="A/B=229-512"/>
</dbReference>
<dbReference type="PDB" id="2GQG">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B=229-500"/>
</dbReference>
<dbReference type="PDB" id="2HIW">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A/B=230-512"/>
</dbReference>
<dbReference type="PDB" id="2HYY">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B/C/D=228-500"/>
</dbReference>
<dbReference type="PDB" id="2HZ0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A/B=228-497"/>
</dbReference>
<dbReference type="PDB" id="2HZ4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/B/C=228-500"/>
</dbReference>
<dbReference type="PDB" id="2HZI">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A/B=229-500"/>
</dbReference>
<dbReference type="PDB" id="2O88">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.75"/>
<property type="chains" value="A/B=64-121"/>
</dbReference>
<dbReference type="PDB" id="2V7A">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B=229-512"/>
</dbReference>
<dbReference type="PDB" id="3CS9">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.21"/>
<property type="chains" value="A/B/C/D=229-500"/>
</dbReference>
<dbReference type="PDB" id="3EG0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=60-121"/>
</dbReference>
<dbReference type="PDB" id="3EG1">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.85"/>
<property type="chains" value="A/B=60-121"/>
</dbReference>
<dbReference type="PDB" id="3EG2">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=60-121"/>
</dbReference>
<dbReference type="PDB" id="3EG3">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.40"/>
<property type="chains" value="A=60-121"/>
</dbReference>
<dbReference type="PDB" id="3EGU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.25"/>
<property type="chains" value="A=60-121"/>
</dbReference>
<dbReference type="PDB" id="3K2M">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.75"/>
<property type="chains" value="A/B=121-232"/>
</dbReference>
<dbReference type="PDB" id="3PYY">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.85"/>
<property type="chains" value="A/B=229-512"/>
</dbReference>
<dbReference type="PDB" id="3QRI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A/B=229-499"/>
</dbReference>
<dbReference type="PDB" id="3QRJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.82"/>
<property type="chains" value="A/B=229-499"/>
</dbReference>
<dbReference type="PDB" id="3QRK">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=229-499"/>
</dbReference>
<dbReference type="PDB" id="3T04">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=112-232"/>
</dbReference>
<dbReference type="PDB" id="3UE4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.42"/>
<property type="chains" value="A/B=229-512"/>
</dbReference>
<dbReference type="PDB" id="3UYO">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.83"/>
<property type="chains" value="A=112-232"/>
</dbReference>
<dbReference type="PDB" id="4J9B">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=60-121"/>
</dbReference>
<dbReference type="PDB" id="4J9C">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.05"/>
<property type="chains" value="A=60-121"/>
</dbReference>
<dbReference type="PDB" id="4J9D">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.50"/>
<property type="chains" value="A/C/E=60-121"/>
</dbReference>
<dbReference type="PDB" id="4J9E">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.40"/>
<property type="chains" value="A/C/E=60-121"/>
</dbReference>
<dbReference type="PDB" id="4J9F">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.09"/>
<property type="chains" value="A/C/E=60-121"/>
</dbReference>
<dbReference type="PDB" id="4J9G">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A/C/E=60-121"/>
</dbReference>
<dbReference type="PDB" id="4J9H">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A/B/C/D/E/F=60-121"/>
</dbReference>
<dbReference type="PDB" id="4J9I">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A/C/E=60-121"/>
</dbReference>
<dbReference type="PDB" id="4JJB">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.65"/>
<property type="chains" value="A=60-121"/>
</dbReference>
<dbReference type="PDB" id="4JJC">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="A=60-121"/>
</dbReference>
<dbReference type="PDB" id="4JJD">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="A=60-121"/>
</dbReference>
<dbReference type="PDB" id="4TWP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B=233-503"/>
</dbReference>
<dbReference type="PDB" id="4WA9">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A/B=246-512"/>
</dbReference>
<dbReference type="PDB" id="4XEY">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.89"/>
<property type="chains" value="A/B=119-515"/>
</dbReference>
<dbReference type="PDB" id="4YC8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A/B=229-512"/>
</dbReference>
<dbReference type="PDB" id="4ZOG">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B=229-511"/>
</dbReference>
<dbReference type="PDB" id="5DC0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.23"/>
<property type="chains" value="B=112-232"/>
</dbReference>
<dbReference type="PDB" id="5DC4">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.48"/>
<property type="chains" value="A=112-232"/>
</dbReference>
<dbReference type="PDB" id="5DC9">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.56"/>
<property type="chains" value="A=112-232"/>
</dbReference>
<dbReference type="PDB" id="5HU9">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.53"/>
<property type="chains" value="A=229-500"/>
</dbReference>
<dbReference type="PDB" id="5MO4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.17"/>
<property type="chains" value="A=27-515"/>
</dbReference>
<dbReference type="PDB" id="5OAZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.03"/>
<property type="chains" value="A/B=60-121"/>
</dbReference>
<dbReference type="PDB" id="6AMV">
<property type="method" value="NMR"/>
<property type="chains" value="A=26-236"/>
</dbReference>
<dbReference type="PDB" id="6AMW">
<property type="method" value="NMR"/>
<property type="chains" value="A=26-236"/>
</dbReference>
<dbReference type="PDBsum" id="1AB2"/>
<dbReference type="PDBsum" id="1ABL"/>
<dbReference type="PDBsum" id="1AWO"/>
<dbReference type="PDBsum" id="1BBZ"/>
<dbReference type="PDBsum" id="1JU5"/>
<dbReference type="PDBsum" id="1OPL"/>
<dbReference type="PDBsum" id="1ZZP"/>
<dbReference type="PDBsum" id="2ABL"/>
<dbReference type="PDBsum" id="2E2B"/>
<dbReference type="PDBsum" id="2F4J"/>
<dbReference type="PDBsum" id="2FO0"/>
<dbReference type="PDBsum" id="2G1T"/>
<dbReference type="PDBsum" id="2G2F"/>
<dbReference type="PDBsum" id="2G2H"/>
<dbReference type="PDBsum" id="2G2I"/>
<dbReference type="PDBsum" id="2GQG"/>
<dbReference type="PDBsum" id="2HIW"/>
<dbReference type="PDBsum" id="2HYY"/>
<dbReference type="PDBsum" id="2HZ0"/>
<dbReference type="PDBsum" id="2HZ4"/>
<dbReference type="PDBsum" id="2HZI"/>
<dbReference type="PDBsum" id="2O88"/>
<dbReference type="PDBsum" id="2V7A"/>
<dbReference type="PDBsum" id="3CS9"/>
<dbReference type="PDBsum" id="3EG0"/>
<dbReference type="PDBsum" id="3EG1"/>
<dbReference type="PDBsum" id="3EG2"/>
<dbReference type="PDBsum" id="3EG3"/>
<dbReference type="PDBsum" id="3EGU"/>
<dbReference type="PDBsum" id="3K2M"/>
<dbReference type="PDBsum" id="3PYY"/>
<dbReference type="PDBsum" id="3QRI"/>
<dbReference type="PDBsum" id="3QRJ"/>
<dbReference type="PDBsum" id="3QRK"/>
<dbReference type="PDBsum" id="3T04"/>
<dbReference type="PDBsum" id="3UE4"/>
<dbReference type="PDBsum" id="3UYO"/>
<dbReference type="PDBsum" id="4J9B"/>
<dbReference type="PDBsum" id="4J9C"/>
<dbReference type="PDBsum" id="4J9D"/>
<dbReference type="PDBsum" id="4J9E"/>
<dbReference type="PDBsum" id="4J9F"/>
<dbReference type="PDBsum" id="4J9G"/>
<dbReference type="PDBsum" id="4J9H"/>
<dbReference type="PDBsum" id="4J9I"/>
<dbReference type="PDBsum" id="4JJB"/>
<dbReference type="PDBsum" id="4JJC"/>
<dbReference type="PDBsum" id="4JJD"/>
<dbReference type="PDBsum" id="4TWP"/>
<dbReference type="PDBsum" id="4WA9"/>
<dbReference type="PDBsum" id="4XEY"/>
<dbReference type="PDBsum" id="4YC8"/>
<dbReference type="PDBsum" id="4ZOG"/>
<dbReference type="PDBsum" id="5DC0"/>
<dbReference type="PDBsum" id="5DC4"/>
<dbReference type="PDBsum" id="5DC9"/>
<dbReference type="PDBsum" id="5HU9"/>
<dbReference type="PDBsum" id="5MO4"/>
<dbReference type="PDBsum" id="5OAZ"/>
<dbReference type="PDBsum" id="6AMV"/>
<dbReference type="PDBsum" id="6AMW"/>
<dbReference type="ProteinModelPortal" id="P00519"/>
<dbReference type="SMR" id="P00519"/>
<dbReference type="BioGrid" id="106543">
<property type="interactions" value="187"/>
</dbReference>
<dbReference type="CORUM" id="P00519"/>
<dbReference type="DIP" id="DIP-1042N"/>
<dbReference type="IntAct" id="P00519">
<property type="interactions" value="226"/>
</dbReference>
<dbReference type="MINT" id="MINT-7236141"/>
<dbReference type="STRING" id="9606.ENSP00000361423"/>
<dbReference type="BindingDB" id="P00519"/>
<dbReference type="ChEMBL" id="CHEMBL1862"/>
<dbReference type="DrugBank" id="DB08043">
<property type="generic name" value="1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA"/>
</dbReference>
<dbReference type="DrugBank" id="DB00171">
<property type="generic name" value="Adenosine triphosphate"/>
</dbReference>
<dbReference type="DrugBank" id="DB06616">
<property type="generic name" value="Bosutinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB01254">
<property type="generic name" value="Dasatinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00619">
<property type="generic name" value="Imatinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB08231">
<property type="generic name" value="MYRISTIC ACID"/>
</dbReference>
<dbReference type="DrugBank" id="DB03878">
<property type="generic name" value="N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide"/>
</dbReference>
<dbReference type="DrugBank" id="DB04868">
<property type="generic name" value="Nilotinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB08901">
<property type="generic name" value="Ponatinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB12323">
<property type="generic name" value="Radotinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB08896">
<property type="generic name" value="Regorafenib"/>
</dbReference>
<dbReference type="DrugBank" id="DB05184">
<property type="generic name" value="XL228"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="1923"/>
<dbReference type="iPTMnet" id="P00519"/>
<dbReference type="PhosphoSitePlus" id="P00519"/>
<dbReference type="BioMuta" id="ABL1"/>
<dbReference type="DMDM" id="85681908"/>
<dbReference type="EPD" id="P00519"/>
<dbReference type="MaxQB" id="P00519"/>
<dbReference type="PaxDb" id="P00519"/>
<dbReference type="PeptideAtlas" id="P00519"/>
<dbReference type="PRIDE" id="P00519"/>
<dbReference type="DNASU" id="25"/>
<dbReference type="Ensembl" id="ENST00000318560">
<molecule id="P00519-1"/>
<property type="protein sequence ID" value="ENSP00000323315"/>
<property type="gene ID" value="ENSG00000097007"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000372348">
<molecule id="P00519-2"/>
<property type="protein sequence ID" value="ENSP00000361423"/>
<property type="gene ID" value="ENSG00000097007"/>
</dbReference>
<dbReference type="GeneID" id="25"/>
<dbReference type="KEGG" id="hsa:25"/>
<dbReference type="UCSC" id="uc004bzv.4">
<molecule id="P00519-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="25"/>
<dbReference type="DisGeNET" id="25"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000097007.17"/>
<dbReference type="GeneCards" id="ABL1"/>
<dbReference type="HGNC" id="HGNC:76">
<property type="gene designation" value="ABL1"/>
</dbReference>
<dbReference type="HPA" id="CAB002686"/>
<dbReference type="HPA" id="HPA027251"/>
<dbReference type="HPA" id="HPA027280"/>
<dbReference type="HPA" id="HPA028409"/>
<dbReference type="MalaCards" id="ABL1"/>
<dbReference type="MIM" id="189980">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="608232">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="617602">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P00519"/>
<dbReference type="OpenTargets" id="ENSG00000097007"/>
<dbReference type="Orphanet" id="521">
<property type="disease" value="Chronic myeloid leukemia"/>
</dbReference>
<dbReference type="Orphanet" id="99860">
<property type="disease" value="Precursor B-cell acute lymphoblastic leukemia"/>
</dbReference>
<dbReference type="Orphanet" id="99861">
<property type="disease" value="Precursor T-cell acute lymphoblastic leukemia"/>
</dbReference>
<dbReference type="PharmGKB" id="PA24413"/>
<dbReference type="eggNOG" id="KOG0197">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG0515">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000119011"/>
<dbReference type="HOVERGEN" id="HBG004162"/>
<dbReference type="InParanoid" id="P00519"/>
<dbReference type="KO" id="K06619"/>
<dbReference type="OMA" id="GAFRESG"/>
<dbReference type="OrthoDB" id="EOG091G0D46"/>
<dbReference type="PhylomeDB" id="P00519"/>
<dbReference type="TreeFam" id="TF105081"/>
<dbReference type="BRENDA" id="2.7.10.2">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2029482">
<property type="pathway name" value="Regulation of actin dynamics for phagocytic cup formation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-375170">
<property type="pathway name" value="CDO in myogenesis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-428890">
<property type="pathway name" value="Role of ABL in ROBO-SLIT signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5663213">
<property type="pathway name" value="RHO GTPases Activate WASPs and WAVEs"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5685938">
<property type="pathway name" value="HDR through Single Strand Annealing (SSA)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693565">
<property type="pathway name" value="Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69231">
<property type="pathway name" value="Cyclin D associated events in G1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8939236">
<property type="pathway name" value="RUNX1 regulates transcription of genes involved in differentiation of HSCs"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8940973">
<property type="pathway name" value="RUNX2 regulates osteoblast differentiation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-983231">
<property type="pathway name" value="Factors involved in megakaryocyte development and platelet production"/>
</dbReference>
<dbReference type="SignaLink" id="P00519"/>
<dbReference type="SIGNOR" id="P00519"/>
<dbReference type="ChiTaRS" id="ABL1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P00519"/>
<dbReference type="GeneWiki" id="ABL_(gene)"/>
<dbReference type="GenomeRNAi" id="25"/>
<dbReference type="PMAP-CutDB" id="P00519"/>
<dbReference type="PRO" id="PR:P00519"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 9"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000097007"/>
<dbReference type="CleanEx" id="HS_ABL1"/>
<dbReference type="ExpressionAtlas" id="P00519">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P00519">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0015629">
<property type="term" value="C:actin cytoskeleton"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031252">
<property type="term" value="C:cell leading edge"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0030425">
<property type="term" value="C:dendrite"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031234">
<property type="term" value="C:extrinsic component of cytoplasmic side of plasma membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005739">
<property type="term" value="C:mitochondrion"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043025">
<property type="term" value="C:neuronal cell body"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016604">
<property type="term" value="C:nuclear body"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0031965">
<property type="term" value="C:nuclear membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005730">
<property type="term" value="C:nucleolus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048471">
<property type="term" value="C:perinuclear region of cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0098794">
<property type="term" value="C:postsynapse"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043234">
<property type="term" value="C:protein complex"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0051015">
<property type="term" value="F:actin filament binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0003785">
<property type="term" value="F:actin monomer binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046875">
<property type="term" value="F:ephrin receptor binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016301">
<property type="term" value="F:kinase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000287">
<property type="term" value="F:magnesium ion binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030145">
<property type="term" value="F:manganese ion binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051019">
<property type="term" value="F:mitogen-activated protein kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0038191">
<property type="term" value="F:neuropilin binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0004515">
<property type="term" value="F:nicotinate-nucleotide adenylyltransferase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004715">
<property type="term" value="F:non-membrane spanning protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001784">
<property type="term" value="F:phosphotyrosine residue binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0070064">
<property type="term" value="F:proline-rich region binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008022">
<property type="term" value="F:protein C-terminus binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004672">
<property type="term" value="F:protein kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005080">
<property type="term" value="F:protein kinase C binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0004713">
<property type="term" value="F:protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005102">
<property type="term" value="F:receptor binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0042169">
<property type="term" value="F:SH2 domain binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0017124">
<property type="term" value="F:SH3 domain binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019905">
<property type="term" value="F:syntaxin binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030036">
<property type="term" value="P:actin cytoskeleton organization"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090135">
<property type="term" value="P:actin filament branching"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050798">
<property type="term" value="P:activated T cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1990051">
<property type="term" value="P:activation of protein kinase C activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046632">
<property type="term" value="P:alpha-beta T cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006914">
<property type="term" value="P:autophagy"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0002322">
<property type="term" value="P:B cell proliferation involved in immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050853">
<property type="term" value="P:B cell receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001922">
<property type="term" value="P:B-1 B cell homeostasis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060020">
<property type="term" value="P:Bergmann glial cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0072358">
<property type="term" value="P:cardiovascular system development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007050">
<property type="term" value="P:cell cycle arrest"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006464">
<property type="term" value="P:cellular protein modification process"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006974">
<property type="term" value="P:cellular response to DNA damage stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1903351">
<property type="term" value="P:cellular response to dopamine"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070301">
<property type="term" value="P:cellular response to hydrogen peroxide"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071222">
<property type="term" value="P:cellular response to lipopolysaccharide"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034599">
<property type="term" value="P:cellular response to oxidative stress"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0021587">
<property type="term" value="P:cerebellum morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048668">
<property type="term" value="P:collateral sprouting"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006975">
<property type="term" value="P:DNA damage induced protein phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043542">
<property type="term" value="P:endothelial cell migration"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007173">
<property type="term" value="P:epidermal growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045184">
<property type="term" value="P:establishment of protein localization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0038096">
<property type="term" value="P:Fc-gamma receptor signaling pathway involved in phagocytosis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0007229">
<property type="term" value="P:integrin-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008630">
<property type="term" value="P:intrinsic apoptotic signaling pathway in response to DNA damage"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030035">
<property type="term" value="P:microspike assembly"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006298">
<property type="term" value="P:mismatch repair"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0051882">
<property type="term" value="P:mitochondrial depolarization"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000278">
<property type="term" value="P:mitotic cell cycle"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030514">
<property type="term" value="P:negative regulation of BMP signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0022408">
<property type="term" value="P:negative regulation of cell-cell adhesion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2000773">
<property type="term" value="P:negative regulation of cellular senescence"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2000352">
<property type="term" value="P:negative regulation of endothelial cell apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070373">
<property type="term" value="P:negative regulation of ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043124">
<property type="term" value="P:negative regulation of I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1900272">
<property type="term" value="P:negative regulation of long-term synaptic potentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045930">
<property type="term" value="P:negative regulation of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1900275">
<property type="term" value="P:negative regulation of phospholipase C activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0071901">
<property type="term" value="P:negative regulation of protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051444">
<property type="term" value="P:negative regulation of ubiquitin-protein transferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0001843">
<property type="term" value="P:neural tube closure"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060563">
<property type="term" value="P:neuroepithelial cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050885">
<property type="term" value="P:neuromuscular process controlling balance"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0038189">
<property type="term" value="P:neuropilin signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0038083">
<property type="term" value="P:peptidyl-tyrosine autophosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0018108">
<property type="term" value="P:peptidyl-tyrosine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035791">
<property type="term" value="P:platelet-derived growth factor receptor-beta signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1905555">
<property type="term" value="P:positive regulation blood vessel branching"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2000251">
<property type="term" value="P:positive regulation of actin cytoskeleton reorganization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1904531">
<property type="term" value="P:positive regulation of actin filament binding"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043065">
<property type="term" value="P:positive regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090050">
<property type="term" value="P:positive regulation of cell migration involved in sprouting angiogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007204">
<property type="term" value="P:positive regulation of cytosolic calcium ion concentration"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0010595">
<property type="term" value="P:positive regulation of endothelial cell migration"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070374">
<property type="term" value="P:positive regulation of ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051894">
<property type="term" value="P:positive regulation of focal adhesion assembly"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043123">
<property type="term" value="P:positive regulation of I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1902715">
<property type="term" value="P:positive regulation of interferon-gamma secretion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1900042">
<property type="term" value="P:positive regulation of interleukin-2 secretion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1904528">
<property type="term" value="P:positive regulation of microtubule binding"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045931">
<property type="term" value="P:positive regulation of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051149">
<property type="term" value="P:positive regulation of muscle cell differentiation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:1901216">
<property type="term" value="P:positive regulation of neuron death"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0033690">
<property type="term" value="P:positive regulation of osteoblast proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051353">
<property type="term" value="P:positive regulation of oxidoreductase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050731">
<property type="term" value="P:positive regulation of peptidyl-tyrosine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001934">
<property type="term" value="P:positive regulation of protein phosphorylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051281">
<property type="term" value="P:positive regulation of release of sequestered calcium ion into cytosol"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051496">
<property type="term" value="P:positive regulation of stress fiber assembly"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1900026">
<property type="term" value="P:positive regulation of substrate adhesion-dependent cell spreading"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2000096">
<property type="term" value="P:positive regulation of Wnt signaling pathway, planar cell polarity pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009791">
<property type="term" value="P:post-embryonic development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046777">
<property type="term" value="P:protein autophosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006468">
<property type="term" value="P:protein phosphorylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032956">
<property type="term" value="P:regulation of actin cytoskeleton organization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000249">
<property type="term" value="P:regulation of actin cytoskeleton reorganization"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010506">
<property type="term" value="P:regulation of autophagy"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030516">
<property type="term" value="P:regulation of axon extension"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032489">
<property type="term" value="P:regulation of Cdc42 protein signal transduction"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030155">
<property type="term" value="P:regulation of cell adhesion"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000145">
<property type="term" value="P:regulation of cell motility"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042127">
<property type="term" value="P:regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0030100">
<property type="term" value="P:regulation of endocytosis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1903053">
<property type="term" value="P:regulation of extracellular matrix organization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1902036">
<property type="term" value="P:regulation of hematopoietic stem cell differentiation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0031113">
<property type="term" value="P:regulation of microtubule polymerization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1905244">
<property type="term" value="P:regulation of modification of synaptic structure"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2001020">
<property type="term" value="P:regulation of response to DNA damage stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045580">
<property type="term" value="P:regulation of T cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006355">
<property type="term" value="P:regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0006979">
<property type="term" value="P:response to oxidative stress"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0042770">
<property type="term" value="P:signal transduction in response to DNA damage"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048536">
<property type="term" value="P:spleen development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034446">
<property type="term" value="P:substrate adhesion-dependent cell spreading"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048538">
<property type="term" value="P:thymus development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002333">
<property type="term" value="P:transitional one stage B cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="CDD" id="cd09935">
<property type="entry name" value="SH2_ABL"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.505.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR033221">
<property type="entry name" value="ABL1"/>
</dbReference>
<dbReference type="InterPro" id="IPR035837">
<property type="entry name" value="ABL_SH2"/>
</dbReference>
<dbReference type="InterPro" id="IPR015015">
<property type="entry name" value="F-actin_binding"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR001245">
<property type="entry name" value="Ser-Thr/Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR000980">
<property type="entry name" value="SH2"/>
</dbReference>
<dbReference type="InterPro" id="IPR036860">
<property type="entry name" value="SH2_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR036028">
<property type="entry name" value="SH3-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR001452">
<property type="entry name" value="SH3_domain"/>
</dbReference>
<dbReference type="InterPro" id="IPR008266">
<property type="entry name" value="Tyr_kinase_AS"/>
</dbReference>
<dbReference type="InterPro" id="IPR020635">
<property type="entry name" value="Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24418:SF88">
<property type="entry name" value="PTHR24418:SF88"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF08919">
<property type="entry name" value="F_actin_bind"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF07714">
<property type="entry name" value="Pkinase_Tyr"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00017">
<property type="entry name" value="SH2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00018">
<property type="entry name" value="SH3_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00401">
<property type="entry name" value="SH2DOMAIN"/>
</dbReference>
<dbReference type="PRINTS" id="PR00109">
<property type="entry name" value="TYRKINASE"/>
</dbReference>
<dbReference type="SMART" id="SM00808">
<property type="entry name" value="FABD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00252">
<property type="entry name" value="SH2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00326">
<property type="entry name" value="SH3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00219">
<property type="entry name" value="TyrKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF50044">
<property type="entry name" value="SSF50044"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF55550">
<property type="entry name" value="SSF55550"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00109">
<property type="entry name" value="PROTEIN_KINASE_TYR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50001">
<property type="entry name" value="SH2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50002">
<property type="entry name" value="SH3"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0072">Autophagy</keyword>
<keyword id="KW-0130">Cell adhesion</keyword>
<keyword id="KW-0160">Chromosomal rearrangement</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0206">Cytoskeleton</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0227">DNA damage</keyword>
<keyword id="KW-0234">DNA repair</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-0254">Endocytosis</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0449">Lipoprotein</keyword>
<keyword id="KW-0460">Magnesium</keyword>
<keyword id="KW-0464">Manganese</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0496">Mitochondrion</keyword>
<keyword id="KW-0519">Myristate</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0656">Proto-oncogene</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0727">SH2 domain</keyword>
<keyword id="KW-0728">SH3 domain</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0829">Tyrosine-protein kinase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Tyrosine-protein kinase ABL1" id="PRO_0000088050">
<location>
<begin position="1"/>
<end position="1130"/>
</location>
</feature>
<feature type="domain" description="SH3" evidence="30">
<location>
<begin position="61"/>
<end position="121"/>
</location>
</feature>
<feature type="domain" description="SH2" evidence="29">
<location>
<begin position="127"/>
<end position="217"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="28">
<location>
<begin position="242"/>
<end position="493"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP">
<location>
<begin position="248"/>
<end position="256"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP">
<location>
<begin position="316"/>
<end position="322"/>
</location>
</feature>
<feature type="region of interest" description="CAP">
<location>
<begin position="1"/>
<end position="60"/>
</location>
</feature>
<feature type="region of interest" description="DNA-binding" evidence="24">
<location>
<begin position="869"/>
<end position="968"/>
</location>
</feature>
<feature type="region of interest" description="F-actin-binding">
<location>
<begin position="953"/>
<end position="1130"/>
</location>
</feature>
<feature type="short sequence motif" description="Kinase activation loop">
<location>
<begin position="381"/>
<end position="405"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal 1" evidence="27">
<location>
<begin position="605"/>
<end position="609"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal 2" evidence="27">
<location>
<begin position="709"/>
<end position="715"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal 3" evidence="27">
<location>
<begin position="762"/>
<end position="769"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear export signal" evidence="24">
<location>
<begin position="1090"/>
<end position="1100"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ser">
<location>
<begin position="18"/>
<end position="22"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Lys">
<location>
<begin position="605"/>
<end position="609"/>
</location>
</feature>
<feature type="compositionally biased region" description="Pro-rich">
<location>
<begin position="782"/>
<end position="1019"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Pro">
<location>
<begin position="897"/>
<end position="903"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="28 31">
<location>
<position position="363"/>
</location>
</feature>
<feature type="binding site" description="ATP">
<location>
<position position="271"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form BCR-ABL oncogene">
<location>
<begin position="26"/>
<end position="27"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="19 21 49">
<location>
<position position="50"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="52 60">
<location>
<position position="70"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="52">
<location>
<position position="115"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="52">
<location>
<position position="128"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="52">
<location>
<position position="139"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="52">
<location>
<position position="172"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="52">
<location>
<position position="185"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="52">
<location>
<position position="215"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="52">
<location>
<position position="226"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="26">
<location>
<position position="229"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="22">
<location>
<position position="253"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="22">
<location>
<position position="257"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis and SRC-type Tyr-kinases" evidence="52">
<location>
<position position="393"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="22">
<location>
<position position="413"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="25">
<location>
<position position="446"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="22">
<location>
<position position="559"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="17 18 19 20 21 22 23">
<location>
<position position="569"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PAK2" evidence="58">
<location>
<position position="618"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PAK2" evidence="58">
<location>
<position position="619"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="22">
<location>
<position position="620"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="19">
<location>
<position position="659"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="22">
<location>
<position position="683"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; by EP300" evidence="50">
<location>
<position position="711"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="22">
<location>
<position position="718"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="46">
<location>
<position position="735"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="22">
<location>
<position position="751"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="22">
<location>
<position position="781"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="19">
<location>
<position position="814"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="22">
<location>
<position position="823"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="19 22">
<location>
<position position="844"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="18 22">
<location>
<position position="852"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="22">
<location>
<position position="855"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="18 22">
<location>
<position position="917"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="19">
<location>
<position position="977"/>
</location>
</feature>
<feature type="splice variant" description="In isoform IB." id="VSP_004957" evidence="76">
<original>MLEICLKLVGCKSKKGLSSSSSCYLE</original>
<variation>MGQQPGKVLGDQRRPSLPALHFIKGAGKKESSRHGGPHCNVFVEH</variation>
<location>
<begin position="1"/>
<end position="26"/>
</location>
</feature>
<feature type="sequence variant" description="In a lung large cell carcinoma sample; somatic mutation." id="VAR_032676" evidence="55">
<original>R</original>
<variation>G</variation>
<location>
<position position="47"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1064152." id="VAR_051692" evidence="71">
<original>L</original>
<variation>P</variation>
<location>
<position position="140"/>
</location>
</feature>
<feature type="sequence variant" description="In a melanoma sample; somatic mutation." id="VAR_032677" evidence="55">
<original>R</original>
<variation>K</variation>
<location>
<position position="166"/>
</location>
</feature>
<feature type="sequence variant" description="In CHDSKM; increases kinase activity; no effect on protein levels." id="VAR_079482" evidence="69">
<original>Y</original>
<variation>C</variation>
<location>
<position position="226"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34549764." id="VAR_051693">
<original>K</original>
<variation>R</variation>
<location>
<position position="247"/>
</location>
</feature>
<feature type="sequence variant" description="In CHDSKM; increases kinase activity; no effect on protein levels." id="VAR_079483" evidence="69">
<original>A</original>
<variation>T</variation>
<location>
<position position="337"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34634745." id="VAR_025043" evidence="55 75">
<original>G</original>
<variation>V</variation>
<location>
<position position="706"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2229071." id="VAR_032678" evidence="55">
<original>P</original>
<variation>L</variation>
<location>
<position position="810"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_025044" evidence="75">
<original>T</original>
<variation>P</variation>
<location>
<position position="852"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35266696." id="VAR_025045" evidence="75">
<original>P</original>
<variation>S</variation>
<location>
<position position="900"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1064165." id="VAR_051694">
<original>S</original>
<variation>P</variation>
<location>
<position position="968"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2229067." id="VAR_025046" evidence="55 75">
<original>S</original>
<variation>L</variation>
<location>
<position position="972"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphorylation. Loss of binding YWHAS and YWHAZ. Localizes to the nucleus. No effect on kinase activity." evidence="46">
<original>T</original>
<variation>A</variation>
<location>
<position position="735"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA51561." ref="1" evidence="77">
<original>G</original>
<variation>S</variation>
<location>
<position position="159"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 9." ref="9" evidence="77">
<original>AF</original>
<variation>GK</variation>
<location>
<begin position="424"/>
<end position="425"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA51561." ref="1" evidence="77">
<original>L</original>
<variation>R</variation>
<location>
<position position="445"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA51561." ref="1" evidence="77">
<original>E</original>
<variation>K</variation>
<location>
<position position="459"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA51561." ref="1" evidence="77">
<original>S</original>
<variation>T</variation>
<location>
<position position="520"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA51561." ref="1" evidence="77">
<original>A</original>
<variation>V</variation>
<location>
<position position="719"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAA34438." ref="2" evidence="77">
<original>G</original>
<variation>E</variation>
<location>
<position position="837"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA51561." ref="1" evidence="77">
<original>G</original>
<variation>W</variation>
<location>
<position position="837"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA51561." ref="1" evidence="77">
<original>G</original>
<variation>R</variation>
<location>
<position position="863"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA51561." ref="1" evidence="77">
<original>R</original>
<variation>K</variation>
<location>
<position position="894"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA51561." ref="1" evidence="77">
<original>SPS</original>
<variation>RPG</variation>
<location>
<begin position="917"/>
<end position="919"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA51561." ref="1" evidence="77">
<original>G</original>
<variation>A</variation>
<location>
<position position="952"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA51561." ref="1" evidence="77">
<original>QS</original>
<variation>HP</variation>
<location>
<begin position="967"/>
<end position="968"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA51561." ref="1" evidence="77">
<original>P</original>
<variation>PL</variation>
<location>
<position position="982"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA51561." ref="1" evidence="77">
<location>
<position position="1022"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA51561." ref="1" evidence="77">
<original>R</original>
<variation>G</variation>
<location>
<position position="1045"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA51561." ref="1" evidence="77">
<original>T</original>
<variation>S</variation>
<location>
<position position="1103"/>
</location>
</feature>
<feature type="strand" evidence="16">
<location>
<begin position="26"/>
<end position="32"/>
</location>
</feature>
<feature type="strand" evidence="16">
<location>
<begin position="39"/>
<end position="44"/>
</location>
</feature>
<feature type="turn" evidence="16">
<location>
<begin position="45"/>
<end position="47"/>
</location>
</feature>
<feature type="helix" evidence="16">
<location>
<begin position="50"/>
<end position="52"/>
</location>
</feature>
<feature type="strand" evidence="15">
<location>
<begin position="65"/>
<end position="70"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="76"/>
<end position="79"/>
</location>
</feature>
<feature type="strand" evidence="15">
<location>
<begin position="87"/>
<end position="93"/>
</location>
</feature>
<feature type="strand" evidence="15">
<location>
<begin position="97"/>
<end position="104"/>
</location>
</feature>
<feature type="strand" evidence="15">
<location>
<begin position="107"/>
<end position="112"/>
</location>
</feature>
<feature type="helix" evidence="15">
<location>
<begin position="113"/>
<end position="115"/>
</location>
</feature>
<feature type="strand" evidence="15">
<location>
<begin position="116"/>
<end position="118"/>
</location>
</feature>
<feature type="helix" evidence="12">
<location>
<begin position="122"/>
<end position="124"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="128"/>
<end position="131"/>
</location>
</feature>
<feature type="helix" evidence="12">
<location>
<begin position="134"/>
<end position="140"/>
</location>
</feature>
<feature type="turn" evidence="12">
<location>
<begin position="141"/>
<end position="143"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="148"/>
<end position="153"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="155"/>
<end position="157"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="161"/>
<end position="167"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="170"/>
<end position="175"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="177"/>
<end position="179"/>
</location>
</feature>
<feature type="turn" evidence="11">
<location>
<begin position="180"/>
<end position="182"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="184"/>
<end position="187"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="190"/>
<end position="194"/>
</location>
</feature>
<feature type="helix" evidence="12">
<location>
<begin position="195"/>
<end position="202"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="209"/>
<end position="211"/>
</location>
</feature>
<feature type="strand" evidence="14">
<location>
<begin position="226"/>
<end position="228"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="229"/>
<end position="231"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="233"/>
<end position="235"/>
</location>
</feature>
<feature type="helix" evidence="13">
<location>
<begin position="239"/>
<end position="241"/>
</location>
</feature>
<feature type="strand" evidence="13">
<location>
<begin position="242"/>
<end position="247"/>
</location>
</feature>
<feature type="helix" evidence="13">
<location>
<begin position="248"/>
<end position="251"/>
</location>
</feature>
<feature type="strand" evidence="13">
<location>
<begin position="254"/>
<end position="261"/>
</location>
</feature>
<feature type="helix" evidence="13">
<location>
<begin position="262"/>
<end position="264"/>
</location>
</feature>
<feature type="strand" evidence="13">
<location>
<begin position="266"/>
<end position="271"/>
</location>
</feature>
<feature type="turn" evidence="13">
<location>
<begin position="275"/>
<end position="277"/>
</location>
</feature>
<feature type="helix" evidence="13">
<location>
<begin position="280"/>
<end position="290"/>
</location>
</feature>
<feature type="strand" evidence="13">
<location>
<begin position="301"/>
<end position="305"/>
</location>
</feature>
<feature type="strand" evidence="13">
<location>
<begin position="307"/>
<end position="310"/>
</location>
</feature>
<feature type="strand" evidence="13">
<location>
<begin position="312"/>
<end position="316"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="319"/>
<end position="322"/>
</location>
</feature>
<feature type="helix" evidence="13">
<location>
<begin position="323"/>
<end position="329"/>
</location>
</feature>
<feature type="turn" evidence="13">
<location>
<begin position="332"/>
<end position="334"/>
</location>
</feature>
<feature type="helix" evidence="13">
<location>
<begin position="337"/>
<end position="356"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="359"/>
<end position="361"/>
</location>
</feature>
<feature type="helix" evidence="13">
<location>
<begin position="366"/>
<end position="368"/>
</location>
</feature>
<feature type="strand" evidence="13">
<location>
<begin position="369"/>
<end position="371"/>
</location>
</feature>
<feature type="helix" evidence="13">
<location>
<begin position="373"/>
<end position="375"/>
</location>
</feature>
<feature type="strand" evidence="13">
<location>
<begin position="377"/>
<end position="379"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="381"/>
<end position="383"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="384"/>
<end position="387"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="390"/>
<end position="392"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="393"/>
<end position="396"/>
</location>
</feature>
<feature type="strand" evidence="13">
<location>
<begin position="399"/>
<end position="401"/>
</location>
</feature>
<feature type="helix" evidence="13">
<location>
<begin position="403"/>
<end position="405"/>
</location>
</feature>
<feature type="helix" evidence="13">
<location>
<begin position="408"/>
<end position="413"/>
</location>
</feature>
<feature type="helix" evidence="13">
<location>
<begin position="418"/>
<end position="433"/>
</location>
</feature>
<feature type="helix" evidence="13">
<location>
<begin position="445"/>
<end position="447"/>
</location>
</feature>
<feature type="helix" evidence="13">
<location>
<begin position="448"/>
<end position="453"/>
</location>
</feature>
<feature type="helix" evidence="13">
<location>
<begin position="466"/>
<end position="475"/>
</location>
</feature>
<feature type="helix" evidence="13">
<location>
<begin position="480"/>
<end position="482"/>
</location>
</feature>
<feature type="helix" evidence="13">
<location>
<begin position="486"/>
<end position="496"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="498"/>
<end position="500"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="503"/>
<end position="506"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="510"/>
<end position="512"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="1029"/>
<end position="1045"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="1046"/>
<end position="1048"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="1053"/>
<end position="1070"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="1071"/>
<end position="1073"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="1080"/>
<end position="1097"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="1101"/>
<end position="1104"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="1106"/>
<end position="1108"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="1115"/>
<end position="1128"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1OPL"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1ZZP"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2F4J"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2G1T"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2G2F"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2G2H"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2GQG"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2HZI"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3EG3"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3QRJ"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4XEY"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5DC4"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5HU9"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5MO4"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5OAZ"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6AMV"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19369195"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000250"/>
<evidence key="25" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P00520"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P42684"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000255"/>
<evidence key="28" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00191"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00192"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10028"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10194451"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10391250"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11374898"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11971963"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12379650"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12384576"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12475393"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12531427"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12654251"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12672821"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15031292"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15302586"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15556646"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15657060"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15696159"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15886098"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16424036"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16543148"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16648821"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16678104"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16912036"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16943190"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17306540"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17452790"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17623672"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18161990"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18328268"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18775435"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18945674"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19381274"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19891780"/>
</source>
</evidence>
<evidence key="64" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19906645"/>
</source>
</evidence>
<evidence key="65" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20357770"/>
</source>
</evidence>
<evidence key="66" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20417104"/>
</source>
</evidence>
<evidence key="67" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20861316"/>
</source>
</evidence>
<evidence key="68" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23006999"/>
</source>
</evidence>
<evidence key="69" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28288113"/>
</source>
</evidence>
<evidence key="70" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28428613"/>
</source>
</evidence>
<evidence key="71" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3021337"/>
</source>
</evidence>
<evidence key="72" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9037071"/>
</source>
</evidence>
<evidence key="73" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9144171"/>
</source>
</evidence>
<evidence key="74" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9461559"/>
</source>
</evidence>
<evidence key="75" type="ECO:0000269">
<source ref="4"/>
</evidence>
<evidence key="76" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="77" type="ECO:0000305"/>
<sequence length="1130" mass="122873" checksum="85FE6C1C0E483EA2" modified="2006-01-24" version="4">
MLEICLKLVGCKSKKGLSSSSSCYLEEALQRPVASDFEPQGLSEAARWNSKENLLAGPSE
NDPNLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVN
SLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTAS
DGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERT
DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ
LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFI
HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS
DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNP
SDRPSFAEIHQAFETMFQESSISDEVEKELGKQGVRGAVSTLLQAPELPTKTRTSRRAAE
HRDTTDVPEMPHSKGQGESDPLDHEPAVSPLLPRKERGPPEGGLNEDERLLPKDKKTNLF
SALIKKKKKTAPTPPKRSSSFREMDGQPERRGAGEEEGRDISNGALAFTPLDTADPAKSP
KPSNGAGVPNGALRESGGSGFRSPHLWKKSSTLTSSRLATGEEEGGGSSSKRFLRSCSAS
CVPHGAKDTEWRSVTLPRDLQSTGRQFDSSTFGGHKSEKPALPRKRAGENRSDQVTRGTV
TPPPRLVKKNEEAADEVFKDIMESSPGSSPPNLTPKPLRRQVTVAPASGLPHKEEAGKGS
ALGTPAAAEPVTPTSKAGSGAPGGTSKGPAEESRVRRHKHSSESPGRDKGKLSRLKPAPP
PPPAASAGKAGGKPSQSPSQEAAGEAVLGAKTKATSLVDAVNSDAAKPSQPGEGLKKPVL
PATPKPQSAKPSGTPISPAPVPSTLPSASSALAGDQPSSTAFIPLISTRVSLRKTRQPPE
RIASGAITKGVVLDSTEALCLAISRNSEQMASHSAVLEAGKNLYTFCVSYVDSIQQMRNK
FAFREAINKLENNLRELQICPATAGSGPAATQDFSKLLSSVKEISDIVQR
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>